<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>RDM OCDEM</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4E3E9C16-3AD5-4150-985E-B133A3E08B3E"><gtr:id>4E3E9C16-3AD5-4150-985E-B133A3E08B3E</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Robert</gtr:otherNames><gtr:surname>Johnson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5ADEBA84-AFD6-4FAC-B1B6-16B2436E5CBA"><gtr:id>5ADEBA84-AFD6-4FAC-B1B6-16B2436E5CBA</gtr:id><gtr:firstName>Patrik</gtr:firstName><gtr:surname>Rorsman</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0801995"><gtr:id>A3803249-4E2A-489F-BB91-8D1164C319C8</gtr:id><gtr:title>Characterization of human islet cells: functional and transcriptional studies</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801995</gtr:grantReference><gtr:abstractText>Pancreatic islets play a central role in plasma glucose regulation. They do so by secreting several hormones with key role in glucose homeostasis. In addition, the islet delta-cells secrete somatostatin, a peptide hormone that inhibits both insulin and glucagon release. Type-2 diabetes involves disturbances of both insulin and glucagon release. 

Studies on rodent islets have revealed the fundamental principles about how changes in plasma glucose levels stimulate or inhibit pancreatic islet hormone secretion. It is generally assumed ? without much justification - that data emanating from rodent studies can be extrapolated to man. 

The Human Islet Transplantation Centre in Oxford is one of two islet isolation centres in the UK. Via this centre we now have regular supply of high-quality human pancreatic islets. Over the last two years, we have characterized the electrophysiological and secretory characteristics of human beta-cells. We have found that human beta-cells differ from mouse beta-cells in a number of important ways. 

Collectively, the data obtained so far indicate that it is not possible to extrapolate rodent data to the situation in man. In order to understand the hormone secretion defects that associate with type-2 diabetes in man (rodent diabetes is a rare clinical disorder!), we require a much more detailed picture of the functional characteristics of human islet cells. 

This information should be highly relevant in the ongoing efforts developing new antidiabetic medicines.</gtr:abstractText><gtr:technicalSummary>Pancreatic islets play a central role in plasma glucose regulation. They do so by secreting several hormones with key role in glucose homeostasis. Among these, insulin with a hypoglycaemic action) from the beta-cells and glucagon (hyperglycaemic) from the alpha-cells are the two most important ones. In addition, the islet delta-cells secrete somatostatin, a peptide hormone that inhibits both insulin and glucagon release. Type-2 diabetes involves disturbances of both insulin and glucagon release. 

Studies on islets isolated from rodent islets have revealed the fundamental principles about how changes in plasma glucose levels stimulate or inhibit pancreatic islet hormone secretion. The roles of pathways and proteins identified by such experiments have subsequently been characterized further in mouse models in which key proteins have been genetically ablated. It is assumed that data emanating from rodent studies can be extrapolated to man but this has not been unequivocally confirmed. 

In parallel with the functional studies, efforts to elucidate the genetics of type-2 diabetes have been ongoing. The genome wide scan studies have revolutionized our understanding of the polygenic nature of type-2 diabetes and led to the identification of several novel diabetes genes. However, the interpretation of the genetic data depends heavily on information about gene expression. Obviously, a gene variant is unlikely to affect islet cell function directly if it is not expressed in the islet and vice versa. 

We will i) determine gene transciption in islet cells to document the complements of ion channels, membrane receptors and other genes of interest, ii) perform an electrophysiological characterization of human islet cells and iii) study pancreatic islet hormone seretion from intact human islets in response to glucose in the absence and presence of ion channel and receptor agonists/antagonists.</gtr:technicalSummary><gtr:fund><gtr:end>2012-04-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>589969</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>3175000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Senior Investigator Award</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>095531</gtr:fundingRef><gtr:id>0A0276B3-36F6-4EA4-9D6B-FDB0C0CD0C95</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/86D9426C-E6B7-433E-8A12-AACD3A7E1B77"><gtr:id>86D9426C-E6B7-433E-8A12-AACD3A7E1B77</gtr:id><gtr:title>Chronic palmitate exposure inhibits insulin secretion by dissociation of Ca(2+) channels from secretory granules.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/694816edcd105907b12e230a7b3296d8"><gtr:id>694816edcd105907b12e230a7b3296d8</gtr:id><gtr:otherNames>Hoppa MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/714E6D4C-40F5-4586-A9BF-368840036D82"><gtr:id>714E6D4C-40F5-4586-A9BF-368840036D82</gtr:id><gtr:title>Regulation of glucagon secretion by glucose: paracrine, intrinsic or both?</gtr:title><gtr:parentPublicationTitle>Diabetes, obesity &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7000d31d0b8e5027216cfd7425b06c26"><gtr:id>7000d31d0b8e5027216cfd7425b06c26</gtr:id><gtr:otherNames>Walker JN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1462-8902</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/43E6EDE2-42A6-419B-8687-579C3497BD5E"><gtr:id>43E6EDE2-42A6-419B-8687-579C3497BD5E</gtr:id><gtr:title>SSTR2 is the functionally dominant somatostatin receptor in human pancreatic ?- and a-cells.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/24fa402c2982aad9c84221d7e79628fa"><gtr:id>24fa402c2982aad9c84221d7e79628fa</gtr:id><gtr:otherNames>Kailey B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0193-1849</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4CED98F6-93FC-491C-8BB3-9D301D26601A"><gtr:id>4CED98F6-93FC-491C-8BB3-9D301D26601A</gtr:id><gtr:title>The effects of TAK-875, a selective G protein-coupled receptor 40/free fatty acid 1 agonist, on insulin and glucagon secretion in isolated rat and human islets.</gtr:title><gtr:parentPublicationTitle>The Journal of pharmacology and experimental therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1b78cd6016f2f6550696073e5673d503"><gtr:id>1b78cd6016f2f6550696073e5673d503</gtr:id><gtr:otherNames>Yashiro H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3565</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B881418B-387A-4E7A-B96C-DB5841695712"><gtr:id>B881418B-387A-4E7A-B96C-DB5841695712</gtr:id><gtr:title>Regulation of insulin secretion in human pancreatic islets.</gtr:title><gtr:parentPublicationTitle>Annual review of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f48e8d92732a31fee53db116f9783180"><gtr:id>f48e8d92732a31fee53db116f9783180</gtr:id><gtr:otherNames>Rorsman P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0066-4278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3C29E6E3-CB61-4B2E-9B45-F152BEB803B9"><gtr:id>3C29E6E3-CB61-4B2E-9B45-F152BEB803B9</gtr:id><gtr:title>Diabetes mellitus and the ? cell: the last ten years.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/12b5653c9bea6fd8cb8450b7eb754917"><gtr:id>12b5653c9bea6fd8cb8450b7eb754917</gtr:id><gtr:otherNames>Ashcroft FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9424BF5F-0027-45B9-BBBF-7A0D7EFBDF56"><gtr:id>9424BF5F-0027-45B9-BBBF-7A0D7EFBDF56</gtr:id><gtr:title>Autocrine regulation of insulin secretion.</gtr:title><gtr:parentPublicationTitle>Diabetes, obesity &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cf113a1f04e52ec61e80686b4cf62604"><gtr:id>cf113a1f04e52ec61e80686b4cf62604</gtr:id><gtr:otherNames>Braun M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1462-8902</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D9E6A603-C25E-4544-89B4-A536DE13A5B4"><gtr:id>D9E6A603-C25E-4544-89B4-A536DE13A5B4</gtr:id><gtr:title>Reduced insulin exocytosis in human pancreatic ?-cells with gene variants linked to type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2158fe8fa4edf51d71a8ae5f35ce91b4"><gtr:id>2158fe8fa4edf51d71a8ae5f35ce91b4</gtr:id><gtr:otherNames>Rosengren AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E1F7EABB-6A17-4401-A633-8A24DD818DE4"><gtr:id>E1F7EABB-6A17-4401-A633-8A24DD818DE4</gtr:id><gtr:title>Glucose-responsive beta cells in islets isolated from a patient with long-standing type 1 diabetes mellitus.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7000d31d0b8e5027216cfd7425b06c26"><gtr:id>7000d31d0b8e5027216cfd7425b06c26</gtr:id><gtr:otherNames>Walker JN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1A203BF0-AEB3-4162-B4BE-45FCBBA15DE2"><gtr:id>1A203BF0-AEB3-4162-B4BE-45FCBBA15DE2</gtr:id><gtr:title>Increased Expression of the Diabetes Gene SOX4 Reduces Insulin Secretion by Impaired Fusion Pore Expansion.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4d1b3f7d0b64c59353243e9629c87a47"><gtr:id>4d1b3f7d0b64c59353243e9629c87a47</gtr:id><gtr:otherNames>Collins SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D184370B-90BF-4C66-B4AA-BF6E8D70E92E"><gtr:id>D184370B-90BF-4C66-B4AA-BF6E8D70E92E</gtr:id><gtr:title>Gamma-aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic beta-cells.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cf113a1f04e52ec61e80686b4cf62604"><gtr:id>cf113a1f04e52ec61e80686b4cf62604</gtr:id><gtr:otherNames>Braun M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1058C8AF-F717-42F4-ACA0-1E6A0253B36E"><gtr:id>1058C8AF-F717-42F4-ACA0-1E6A0253B36E</gtr:id><gtr:title>Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cf113a1f04e52ec61e80686b4cf62604"><gtr:id>cf113a1f04e52ec61e80686b4cf62604</gtr:id><gtr:otherNames>Braun M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8C8380AA-08E7-4028-891B-DD9F40BC8DE6"><gtr:id>8C8380AA-08E7-4028-891B-DD9F40BC8DE6</gtr:id><gtr:title>Membrane potential-dependent inactivation of voltage-gated ion channels in alpha-cells inhibits glucagon secretion from human islets.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dda6d0ac8248c0bd7f286d0725ba4918"><gtr:id>dda6d0ac8248c0bd7f286d0725ba4918</gtr:id><gtr:otherNames>Ramracheya R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/007ED586-6D89-4ABD-9481-67B30AF942CA"><gtr:id>007ED586-6D89-4ABD-9481-67B30AF942CA</gtr:id><gtr:title>GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/089fe49c6ccf7a632284fb961817e2c4"><gtr:id>089fe49c6ccf7a632284fb961817e2c4</gtr:id><gtr:otherNames>De Marinis YZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801995</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>